title: Development of new malaria diagnostics: matching performance and need.
abstract: Despite advances in diagnostic technology, significant gaps remain in access to malaria diagnosis. Accurate diagnosis and misdiagnosis leads to unnecessary waste of resources, poor disease management, and contributes to a cycle of poverty in low-resourced communities. Despite much effort and investment, few new technologies have reached the field in the last 30 years aside from lateral flow assays. This suggests that much diagnostic development effort has been misdirected, and/or that there are fundamental blocks to introduction of new technologies. Malaria diagnosis is a difficult market; resources are broadly donor-dependent, health systems in endemic countries are frequently weak, and the epidemiology of malaria and priorities of malaria programmes and donors are evolving. Success in diagnostic development will require a good understanding of programme gaps, and the sustainability of markets to address them. Targeting assay development to such clearly defined market requirements will improve the outcomes of product development funding. Six market segments are identified: (1) case management in low-resourced countries, (2) parasite screening for low density infections in elimination programmes, (3) surveillance for evidence of continued transmission, (4) clinical research and therapeutic efficacy monitoring, (5) cross-checking for microscopy quality control, and (6) returned traveller markets distinguished primarily by resource availability. While each of these markets is potentially compelling from a public health standpoint, size and scale are highly variable and continue to evolve. Consequently, return on investment in research and development may be limited, highlighting the need for potentially significant donor involvement or the introduction of novel business models to overcome prohibitive economics. Given the rather specific applications, a well-defined set of stakeholders will need to be on board for the successful introduction and scaling of any new technology to these markets.
authors: Global Good Fund/Intellectual Ventures Laboratory, 3150 139th Ave SE, Bellevue, WA, 98005, USA. dbell@intven.com.
authors: David
authors: 0000-0002-7010-6340
authors: D
authors: Bell
authors: Concept Foundation, Geneva, Switzerland.
authors: Alessandra E
authors: AE
authors: Fleurent
authors: iSense, LLC, Cambridge, MA, USA.
authors: Michael C
authors: MC
authors: Hegg
authors: Independent Consultant, Seattle, USA.
authors: John D
authors: JD
authors: Boomgard
authors: International Training and Education Center for Health (I-TECH), Gaborone, Botswana.
authors: Caitlin C
authors: CC
authors: McConnico
mesh_terms: D003955:Diagnostic Tests, Routine / Q000379:methods*; D006801:Humans; D008288:Malaria / Q000175:diagnosis*
keywords: Malaria; Malaria diagnostics market; Rapid diagnostic testing; Target product profiles